Avalo Therapeutics, Inc. (AVTX)
19.01
-0.33
(-1.71%)
USD |
NASDAQ |
Sep 03, 16:00
19.01
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Net Income (Annual) : -78.26M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -78.26M |
| December 31, 2024 | -35.13M |
| December 31, 2023 | -31.54M |
| December 31, 2022 | -41.66M |
| December 31, 2021 | -84.35M |
| December 31, 2020 | -64.38M |
| December 31, 2019 | -16.27M |
| Date | Value |
|---|---|
| December 31, 2018 | -36.93M |
| December 31, 2017 | 7.772M |
| December 31, 2016 | -16.47M |
| December 31, 2015 | -10.49M |
| December 31, 2014 | -16.06M |
| December 31, 2013 | -13.04M |
| December 31, 2012 | -10.49M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Incyte Corp. | 1.287B |
| AbbVie, Inc. | 4.193B |
| Rezolute, Inc. | -74.41M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |